Article citationsMore>>

Menzel, C., Kranert, W.T., Döbert, N., Diehl, M., Fietz, T., Hamscho, N., et al. (2003) RhTSH Stimulation before Radioiodine Therapy in Thyroid Cancer Reduces the Effective Half-Life of (131) I. J Nucl Med, 44, 1065-1068.

has been cited by the following article:

• TITLE: Relationship between Whole Body Iodine-131 Effective Half-Life and Estimated Glomerular Filtration Rate for Papillary Thyroid Cancer Patients Undergoing Radioactive Iodine Therapy

  AUTHORS: Asim Abualnaja, Hanaa Alsheikh, Khaled Soliman, Meshal Alnefaie, Abdulraheem Alsheri

  KEYWORDS: GFR, Thyroid Cancer, Radioactive Iodine Therapy, Renal Function

  JOURNAL NAME: Journal of Applied Mathematics and Physics, Vol.11 No.8, August 31, 2023

  ABSTRACT: Background: The aim of this work was to examine the relationship between the estimated glomerular filtration rate (eGFR) as indicator of renal efficiency potentially related to the ability to release radioactive iodine from the patients bodies and the radioactive iodine whole body effective half-life (WBEHL) defined as the time taken for the administered activity to decay to half of its value for papillary thyroid cancer (PTC) patients undergoing radioactive iodine therapy (RAIT) in a tertiary care medical Centre. Methods: This retrospective observational study included seventy nine patients, sixty females and nineteen males. The patients were divided in two subgroups, those who have WBEHL of less than 11 hours (n = 51) and those with more than 11 (n = 28) hrs based on k-means clustering technique. Results: Analysis of variance (ANOVA) was used to find out if there is a statistically significant difference between the two subgroups Conclusion: There was not a statistically significant difference between the short and the longer WBEHL patients’ groups analyzed in this study.